Successful surgical treatment and chemotherapy for ovarian cancer in a patient with idiopathic thrombocytopenic purpura

International Journal of Clinical Oncology

Volumn 16, Issue 4, 2011, Pages 447-449

  Wakana, Kimio ^a   Yasugi, Toshiharu ^a   Nako, Yurie ^a   Nei, Tomomi ^a   Ozaki, Yoshikazu ^a   Mizutani, Katsumi ^a  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

Chemotherapy; Idiopathic thrombocytopenic purpura; Ovarian cancer

Indexed keywords

CA 125 ANTIGEN; CA 195 ANTIGEN; CISPLATIN; DEXAMETHASONE; IMMUNOGLOBULIN; IRINOTECAN; PREDNISOLONE;

ABDOMINAL DISTENSION; ABDOMINAL HYSTERECTOMY; ABDOMINAL PAIN; ABDOMINAL TENDERNESS; ADULT; ARTICLE; ASCITES; CANCER CHEMOTHERAPY; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; ECHOGRAPHY; FEMALE; GYNECOLOGIC SURGERY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LYMPHADENECTOMY; MULTIPLE CYCLE TREATMENT; NAUSEA; OMENTECTOMY; OVARY CANCER; PELVIS TUMOR; PHYSICAL EXAMINATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT DISEASE; SALPINGOOOPHORECTOMY; THROMBOCYTE COUNT; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR VOLUME; VOMITING;

ADENOCARCINOMA, CLEAR CELL; CAMPTOTHECIN; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; POSTOPERATIVE PERIOD; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 80052720328     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-010-0149-3     Document Type: Article

References (8)

1. T Sugiyama M Yakushiji T Kamura Japan CPT-11 Study Group, et al. 2002 Irinotecan (CPT-11) and cisplatin as first-line chemotherapy for advanced ovarian cancer Oncology 63 16 22 12187066 10.1159/000065715 1:CAS:528: DC%2BD38XmtlGitLc%3D (Pubitemid 34977932)
2. R Peffault de Latour G Des Guetz V Laurence, et al. 2004 Breast cancer associated with idiopathic thrombocytopenic purpura: a single center series of 10 cases Am J Clin Oncol 27 333 336 15289724 10.1097/01.COC.0000071461.61445.9A (Pubitemid 39045241)
3. A Chehal A Taher M Seoud, et al. 2003 Idiopathic thrombocytopenic purpura and ovarian cancer Eur J Gynaecol Oncol 24 539 540 14658598 1:STN:280:DC%2BD3srnsl2nsw%3D%3D (Pubitemid 37462576)
4. HM Tarraza R Carroll M De Cain, et al. 1991 Recurrent ovarian carcinoma: presentation as idiopathic thrombocytopenic purpura and a splenic mass Eur J Gynaecol Oncol 12 439 443 1809575 1:STN:280:DyaK383jtlyktA%3D%3D
5. JN George SH Woolf GE Raskob, et al. 1996 Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology Blood 88 3 40 8704187 1:CAS:528:DyaK28XjvFSnsLo%3D (Pubitemid 26230668)
6. Y Cheng RS Wong YO Soo, et al. 2003 Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone N Engl J Med 349 831 836 12944568 10.1056/NEJMoa030254 1:CAS:528:DC%2BD3sXmvVSnsLw%3D (Pubitemid 37025402)
7. RF Ozols BN Bundy BE Greer Gynecologic Oncology Group, et al. 2003 Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study J Clin Oncol 21 3194 3200 12860964 10.1200/JCO.2003.02.153 1:CAS:528:DC%2BD2cXps1aktbk%3D (Pubitemid 46606249)
8. S Takakura M Takano F Takahashi Japanese Gynecologic Oncology Group, et al. 2010 Randomized phase II trial of paclitaxel plus carboplatin therapy versus irinotecan plus cisplatin therapy as first-line chemotherapy for clear cell adenocarcinoma of the ovary: a JGOG study Int J Gynecol Cancer 20 240 247 20169667 10.1111/IGC.0b013e3181cafb47